Dr. Marianna Prokopi-Demetriades is a Clinical Associate Professor in Research Oncology at the Medical School of the European University of Cyprus and co-founder of three certified innovative companies. Although the companies are based in Cyprus, they have an impact on the global biotechnological market. RSL Revolutionary Labs Ltd was founded in 2018 and focuses on the development of innovative dermaceuticals for the relief and healing of skin side effects in oncological patients; Promed Bioscience Ltd was founded in 2017 where it develops medical biomaterials based on 3D-atelocollagen for research and medical applications such as the synthesis of 3D-artificial organs and tissues; and finally Theramir Ltd was founded in 2016 where it develops new generation personalized therapies and diagnostic platforms for cancer based on stem cell nanotechnology and microRNAs. At the same time, Dr. Prokopi is a Senior Scientist in the Dept. of Mechanical Engineering and Materials Science and Engineering at the Cyprus University of Technology and was Director of Research, Innovation and Entrepreneurship at the German Oncology Centre in Limassol until December 2020. She was the winner of Madame Figaro Women of the Year Innovation Awards 2020 and the ASBMB Award in 2021.